The Role of Resistant Starch in COVID-19 Infection
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This study is a multicenter randomized trial to evaluate the efficacy of administering a
dietary supplement containing resistant starch to non-hospitalized COVID-19 positive
subjects, The intervention will begin as soon as possible after subjects test positive for
COVID-19 and continue for 14 days. Investigators hypothesize that short-term administration
of a dietary supplement containing resistant starch has the potential to reduce rates of
hospitalization and improve time to clinical recovery and symptoms in non-hospitalized
COVID-19 positive patients.